sofosbuvir
CHEBI:CHEBI_85083
Definition
A nucleotide conjugate that is used in combination with ledipasvir (under the trade name Harvoni) for the treatment of chronic hepatitis C genotype 1 infection.
Chemical Information
- Molecular Formula
- C22H29FN3O9P
- Molecular Mass
- 529.45250
- Charge
- 0
- SMILES
- CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1
- InChI
- InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1
- InChIKey
- TTZHDVOVKQGIBA-IQWMDFIBSA-N
Alternative Names
- GI 7977
- GS-7977
- isopropyl (2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate
- PSI 7977
- PSI-7977
- Sovaldi
Drug Classification
-
organofluorine compoundView Class →
CHEBI:37143
-
phosphoramidate esterView Class →
CHEBI:27577
-
isopropyl esterView Class →
CHEBI:35725
-
nucleotide conjugateView Class →
CHEBI:47784
-
L-alanyl esterView Class →
CHEBI:61164
-
t309774
-
t310026
-
t310468
-
t310754
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 1484911
- oboInOwl#hasDbXref
- Wikipedia:Sofosbuvir
- core#notation
- CHEBI:85083
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1484911
- oboInOwl#hasDbXref
- Wikipedia:Sofosbuvir
- oboInOwl#id
- CHEBI:85083
- generic_name
- Sofosbuvir
- brand_name
- Sovaldi
- brand_name_base
- Sovaldi
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- route
- ORAL
- dosage_form
- PELLET
- marketing_start_date
- 20131125
- labeler_name
- Gilead Sciences, Inc.
- product_ndc
- 69037-0014
- spl_id
- 0eb681b6-df33-9cfe-e063-6394a90a6e9d
- package_ndc
- 69037-0014-1
- application_number
- NDA204671
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_50266
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_functional_parent
- http://purl.obolibrary.org/obo/CHEBI_16695
- core#notation
- CHEBI:85083
- rxcui
- 2204092
- active_ingredient_strength
- 1 kg/kg
- package_marketing_start_date
- 06-DEC-13
- active_ingredient_name
- SOFOSBUVIR
- unii
- WJ6CA3ZU8B
- nui
- N0000191258
- pharm_class_epc
- Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
- pharm_class
- RNA Replicase Inhibitors [MoA]
- pharm_class_moa
- RNA Replicase Inhibitors [MoA]
- package_description
- 25 kg in 1 DRUM (69037-0014-1)
- manufacturer_name
- Gilead Sciences, Inc.
- spl_set_id
- 80beab2c-396e-4a37-a4dc-40fdb62859cf
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect36838
- owl#annotatedSource
- t310986
- owl#someValuesFrom
- t3861319